1-4 of 4
Tony Navas
Close
Sort by
Journal Articles

Myelosuppresive Effects of Interferon [slpha] and Transforming Growth Factor β Can Be Reversed by Novel p38 MAPK Inhibitor SD-282 through Inhibition of Cell Cycle Arrest.

Mani Mohindru, Perry Pahanish, Robert Collins, Tony Navas, Linda Higgins, Amit Verma
Journal: Blood
Blood (2004) 104 (11): 4229.
https://doi.org/10.1182/blood.V104.11.4229.4229
Published: 2004
Journal Articles

P38 MAPK Inhibition Enhances PS-341 (bortezomib)-Induced Cytotoxicity Against Multiple Myeloma Cells.

Teru Hideshima, MD, PhD, Klaus Podar, MD, PhD, Dharminder Chauhan, PhD, Kenji Ishitsuka, MD, PhD, Constantine Mitsiades, MD, PhD, Yu-Tzu Tai, PhD, Makoto Hamasaki, MD, PhD, Noopur Raje, MD, Hiromasa Hideshima, George Schreiner, MD, PhD, Aaron Nguyen, PhD, Tony Navas, PhD, Nikhil C. Munshi, MD, Paul G. Richardson, MD, Linda S. Higgins, PhD, Kenneth C. Anderson, MD
Journal: Blood
Blood (2004) 104 (11): 3348.
https://doi.org/10.1182/blood.V104.11.3348.3348
Published: 2004
Journal Articles

Novel P38 MAP Kinase Inhibitor and Anti-P38 RNA Interference as Potential Therapeutic Approaches in Myelodysplastic Syndromes.

Mani Mohindru, Perry Pahanish, Efstratios Katsoulidis, Robert Collins, Thomas Rogers, Tony Navas, Linda Higgins, Leonidas Platanias, Amit Verma
Journal: Blood
Blood (2004) 104 (11): 470.
https://doi.org/10.1182/blood.V104.11.470.470
Published: 2004
Journal Articles

p38 alpha MAP Kinase Inhibitor Inhibits Human Myeloma Cell Growth in Vivo.

Mamatha Reddy, M.S, Jing Y. Ma, M.D, Irene Kerr, A.A, Nirupama Henjarappa, B.S, Tony Navas, Ph.D, Jit Chakravarty, Ph.D, Sundeep Dugar, Ph.D, Linda S. Higgins, Ph.D, Andrew A. Protter, Ph.D, Satyanarayana Medicherla, Ph.D
Journal: Blood
Blood (2004) 104 (11): 4936.
https://doi.org/10.1182/blood.V104.11.4936.4936
Published: 2004